• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

AbilTo Launches Tele-Behavioral Program for Substance Use

by Jasmine Pennic 01/20/2016 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

AbilTo

AbilTo, Inc., a provider of evidence-based behavioral change programs proven to improve medical health and lower cost for high-cost medical populations has announced the addition of its Depression and Substance Use program. The new program helps individuals understand the interaction between mood and substance use, and identify strategies to replace use with positive coping skills and healthy reinforcement. 

AbilTo’s Depression and Substance Use program helps participants focus on specific behaviors that influence depression and use. Participants receive non-judgmental, personalized support to modify negative behaviors and practice effective coping skills. They learn to clearly articulate their goals and find ways to increase their self-motivation and efficacy, through a deeper confidence in their ability to change. As with AbilTo’s other program offerings, licensed clinical social workers and behavior coaches provide treatment by telephone or secure video.

The National Institute on Drug Abuse has attributed $166 billion to the cost of healthcare resulting from the abuse of tobacco, alcohol and other drugs. Among those individuals with substance use disorders, sixty percent also suffer from depression. Studies have shown that behavioral change programs, such as those administered by AbilTo, can measurably reduce the cost of care and improve outcomes for these individuals.

“Behavior change, for those who suffer from substance use and depression, can be challenging,” said Aimee Peters, LCSW, chief clinical officer, AbilTo. “Our program acknowledges that the journey toward change is different for each individual, and our providers tailor their approach accordingly. This enables participants to set unique, achievable goals that get them back on the path to happier, healthier and more productive lives.”

The company recently raised $12M in Series C funding last year led by  HLM Venture Partners (HLM) and Yumin Choi, Partner along with previous investors BlueCross BlueShield Venture Partners, .406 Ventures and Sandbox Industries. 

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: AbilTo

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

Aligning IT & Clinical Teams: How to Reduce Friction and Improve Communication

Most-Read

Redesign Health Study: 71% of Health Systems Adopt an "Epic-First" AI Purchasing Strategy

Redesign Health Study: 71% of Health Systems Adopt an “Epic-First” AI Purchasing Strategy

iRhythm to Acquire VitalConnect for $287.5M to Build Broad Cardiac Intelligence Platform

M&A: iRhythm to Acquire VitalConnect for $287.5M to Build Broad Cardiac Intelligence Platform

CB Insights Q2 2026 State of Digital Health Report: Fewest Deals in Over a Decade as Median Sizes Rise

CB Insights Q2 2026 State of Digital Health Report: Fewest Deals in Over a Decade as Median Sizes Rise

mount-sinai-launches-epic-chart-with-art-nursing-ambient-ai

Mount Sinai Medical Center Extends Epic’s Ambient AI to Inpatient Nursing

M&A: Tempus AI to Acquire Personalis for $1.5B to Expand Precision Oncology and MRD Monitoring

M&A: Tempus AI to Acquire Personalis for $1.5B to Expand Precision Oncology and MRD Monitoring

Why Brain Health Is Entering Its Infrastructure Era

Brain Health’s Infrastructure Era: Proving Clinical Outcomes with Integrated Neuromotor Tracking

Why Catholic Health Inked a $500M Care Alliance with GE HealthCare to Automate Outpatient Triage

Catholic Health Inks $500M Care Alliance with GE HealthCare to Automate Outpatient Triage

KLAS Global HIT Trends 2026 Report: Artificial Intelligence Becomes the Top Investment Priority

KLAS Global HIT Trends 2026 Report: Artificial Intelligence Becomes the Top Investment Priority

Optum Partners with Anthropic to Deploy Claude Across Healthcare Claims and Revenue Workflows

Optum Partners with Anthropic to Deploy Claude Across Healthcare Claims and Revenue Workflows

Rock Health H1 2026 Digital Health Funding Recap: Startups Hit $7.4B in Venture Rebound

Rock Health H1 2026 Digital Health Funding Recap: Startups Hit $7.4B in Venture Rebound

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |